Filing Details
- Accession Number:
- 0001127602-21-009288
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 19:23:34
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 19:23:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238334 | Daniel Jonas | C/O Conmed Corp 11311 Concept Boulevard Largo FL 33773 | Evp Legal Affairs,Gen. Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-01 | 3,221 | $39.87 | 16,929 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 3,221 | $123.26 | 13,708 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-01 | 624 | $41.93 | 14,332 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 624 | $123.28 | 13,708 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-01 | 3,500 | $41.93 | 17,208 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 2,345 | $123.20 | 14,863 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2021-03-02 | 2,199 | $39.87 | 17,062 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-02 | 2,199 | $121.84 | 14,863 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-02 | 1,000 | $41.93 | 15,863 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-02 | 1,000 | $121.92 | 14,863 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-02 | 800 | $0.00 | 14,063 | No | 5 | G | Direct | |
Common Stock | Disposition | 2021-03-02 | 150 | $0.00 | 13,913 | No | 5 | G | Direct | |
Common Stock | Disposition | 2021-03-02 | 150 | $0.00 | 13,763 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2021-03-02 | 150 | $0.00 | 450 | No | 5 | G | Indirect | daughter |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 5 | G | Direct | |
No | 5 | G | Direct | |
No | 5 | G | Direct | |
No | 5 | G | Indirect | daughter |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 3,221 | $0.00 | 3,221 | $39.87 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 624 | $0.00 | 624 | $41.93 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 3,500 | $0.00 | 3,500 | $41.93 |
Common Stock | Options To Purchase Common Stock | Acquisiton | 2021-03-01 | 21,250 | $0.00 | 21,250 | $122.55 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-02 | 2,199 | $0.00 | 2,199 | $39.87 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-02 | 1,000 | $0.00 | 1,000 | $41.93 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,199 | 2026-03-01 | No | 4 | M | Direct | |
24,376 | 2027-03-01 | No | 4 | M | Direct | |
20,876 | 2027-03-01 | No | 4 | M | Direct | |
21,250 | 2031-03-01 | No | 4 | A | Direct | |
0 | 2026-03-01 | No | 4 | M | Direct | |
19,876 | 2027-03-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.49. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.405. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.22. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period